Saint

HomeContact Us Newsletter Sign-up

Our Services Find an Event Find a Physician Health Resources Careers About Us

News & Articles
HealthResources
Pregnancy Health Center
Health References
Procedure Information
Drug Information
News & Articles
Health Tools

Daily Health News Provided by Tenet
Today's Articles: Cardiology Category Listing >>
New Novartis transplant drug Certican(r) approved in first European market
Novel proliferation inhibitor increases treatment choice for renal and heart transplant recipients Basel, 23 July, 2003 - Novartis announced today that the Swedish Medical Products Agency has granted marketing authorization for Novartis' new immunosuppressant drug Certican for use in kidney and heart transplantation.
Wyeth's new low dose estrogen tablets approved for prevention of postmenopausal osteoporosis.
Wyeth Pharmaceuticals, a division of Wyeth, announced that the US Food and Drug Administration has approved the 0.3 mg and 0.45 mg dosage strengths of Premarin for the prevention of postmenopausal osteoporosis.
Alteon's ALT-711 shows efficacy against uncontrolled systolic hypertension; pre-specified
Alteon Inc announced initial results from its multi-centre Phase IIb Sapphire and Silver clinical trials of the company's lead AGE Crosslink Breaker, ALT-711, in the treatment of patients with uncontrolled systolic hypertension.
AstraZeneca's Crestor approved by FDA consultative committee.
A consultative committee of the US Food and Drug Administration has recommended the registration of AstraZeneca's Crestor 40 mg . The cholesterol lowering drug will compete with Pfizer's Lipitor which, with sales of $8 bn+ in 2002, was the world's best-selling drug.
Schering-Plough hit by competition.
After registering a 71% decline in its 1Q 2003 profits, Schering-Plough has seen a further fall in 2Q mainly because of a marked fall in US sales of its antiallergenic Claritine in the face of competition from generic products.
Artery thickness linked to parents heart history
LONDON By Health Newswire reporters People whose parents had coronary heart disease before the age of 60 are likely to have thicker neck arteries putting them at increased risk of cardiac disease, US research suggests.
JAMA Study Suggests Equal Benefit for Strict Diet Including Plant Sterol Esters Compared to
LaGRANGE, Ill., July 23 /PRNewswire/ -- Supplementation of plant sterols or sterol esters may be an option in lowering cholesterol for the large population who find it difficult to follow a low-fat diet or for those who prefer not to take cholesterol-lowering medications such as statins.
"Ape diet" reduces cholesterol "as well as drugs"
LONDON By Rael Martell A vegetarian diet composed of specific plant foods, known as the ape diet, can lower cholesterol as effectively as drugs, according to international research.
Guidant receives US approval for first cobalt chromium coronary stent system.
Guidant Corp has received Food and Drug Administration approval for the Multi-Link Vision coronary stent system.
Medtronic announces start of the Endeavor II pivotal clinical trial for its drug-eluting stent;
Medtronic Inc announced the start of the Endeavor II pivotal clinical trial for its Endeavor drug-eluting stent. The trial will evaluate the safety and efficacy of the Endeavor drug-eluting stent and will support product approvals in various countries.
Patients switching to Viramune from a PI-based regimen maintain viral suppression and demonstrate
A new study shows that patients infected with HIV maintained long-term virological suppression while experiencing a significant increase in immune cells and improvement in mean triglyercides and mean serum cholesterol after switching to a Viramune -containing regimen from a protease inhibitor -containing regimen.
Almonds offer hope against killer
IT MAY not be to everyone's taste, but a diet of almonds, soya and oats could be as effective as any medical treatment in lowering cholesterol.
Category Listing >>